Aspirin Patent Expiration
Aspirin is Used for targeting release to the small intestine, reducing fever, and relieving minor aches and pains. It was first introduced by Bayer Healthcare Llc
Aspirin Patents
Given below is the list of patents protecting Aspirin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vazalore | US10646431 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | Sep 29, 2032 | Plx Pharma |
| Vazalore | US10786444 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | Sep 29, 2032 | Plx Pharma |
| Vazalore | US9216150 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | Sep 29, 2032 | Plx Pharma |
| Vazalore | US9226892 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | Sep 29, 2032 | Plx Pharma |
| Vazalore | US8865187 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar 23, 2022
(Expired) | Plx Pharma |
| Vazalore | US9101637 | Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar 23, 2022
(Expired) | Plx Pharma |
| Vazalore | US9351984 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Dec 19, 2021
(Expired) | Plx Pharma |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Aspirin's patents.
Latest Legal Activities on Aspirin's Patents
Given below is the list recent legal activities going on the following patents of Aspirin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 Mar, 2024 | US10786444 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Oct, 2023 | US10646431 |
| Expire Patent Critical | 18 Sep, 2023 | US9101637 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 02 Aug, 2023 | US9226892 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 02 Aug, 2023 | US9226892 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Jun, 2023 | US9216150 |
| Maintenance Fee Reminder Mailed Critical | 03 Apr, 2023 | US9101637 |
| Expire Patent Critical | 28 Nov, 2022 | US8865187 |
| Maintenance Fee Reminder Mailed Critical | 13 Jun, 2022 | US8865187 |
| Recordation of Patent Grant Mailed Critical | 29 Sep, 2020 | US10786444 |
Aspirin's Family Patents
